About: Trius Therapeutics   Sponge Permalink

An Entity of Type : owl:Thing, within Data Space : 134.155.108.49:8890 associated with source dataset(s)

Trius initiated is conducting a phase III trial of tedizolid, an oxazolidinone antibiotic used to treat acute bacterial skin and skin structure infections (ABSSSIs) caused by methicillin-resistant Staphylococcus aureus (MRSA).

AttributesValues
rdfs:label
  • Trius Therapeutics
rdfs:comment
  • Trius initiated is conducting a phase III trial of tedizolid, an oxazolidinone antibiotic used to treat acute bacterial skin and skin structure infections (ABSSSIs) caused by methicillin-resistant Staphylococcus aureus (MRSA).
sameAs
dbkwik:speedydelet...iPageUsesTemplate
concern
  • Recently created corperate stub with a single reference, to the company website. Google reveals lots of press releases and forum posts, but nothing in-depth.
Timestamp
  • 20120722005123(xsd:double)
abstract
  • Trius initiated is conducting a phase III trial of tedizolid, an oxazolidinone antibiotic used to treat acute bacterial skin and skin structure infections (ABSSSIs) caused by methicillin-resistant Staphylococcus aureus (MRSA).
Alternative Linked Data Views: ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3217, on Linux (x86_64-pc-linux-gnu), Standard Edition
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2012 OpenLink Software